Projects per year
Fingerprint
Dive into the research topics where Susan Swindells is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Chronic HIV Infection and Aging in NeuroAIDS (CHAIN) Center
Buch, S. J. (CoPI), Buch, S. J. (PI), Boska, M. D. (CoPI), Ciborowski, P. S. (CoPI), Fox, H. S. (CoPI), Gendelman, H. E. (CoPI), Gorantla, S. (CoPI), Sajja, B. R. (CoPI), Swindells, S. (CoPI), Sarvetnick, N. E. (CoPI), Wilson, T. W. (CoPI), Fox, H. S. (CoPI) & Wood, C. (CoPI)
Project: Research project
-
-
SCRIPPS NEUROAIDS PRECLINICAL STUDIES (SNAPS)
Ciborowski, P. S. (PI), Boska, M. D. (PI), Gendelman, H. E. (PI), Wood, C. (PI), Swindells, S. (PI), Sarvetnick, N. E. (PI), Fox, H. S. (PI), Ideker, T. (PI), Buch, S. (PI), Taffe, M. (PI), Elder, J. (PI), Dawson, P. (PI), Henriksen, S. (PI), Campbell, I. L. (PI), Buch, S. J. (PI), Gorantla, S. (PI), Fox, H. S. (CoPI) & Wilson, T. W. (PI)
9/30/00 → 2/28/17
Project: Research project
-
Adverse Pregnancy Outcomes Among Women with Human Immunodeficiency Virus Taking Isoniazid Preventive Therapy During the First Trimester
for the ACTG 5279 BRIEF-TB study team, Mar 15 2024, In: Clinical Infectious Diseases. 78, 3, p. 667-673 7 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
Facilitators and barriers to adolescent participation in a TB clinical trial
Mangan, J. M., Hedges, K. N. C., Salerno, M. M., Tatum, K., Bouwkamp, B., Frick, M. W., McKenna, L., Muzanyi, G., Engle, M., Coetzee, J., Yvetot, J., Elskamp, M., Lamunu, D., Tizora, M. E. T., Namutamba, D., Chaisson, R. E., Swindells, S., Nahid, P., Dorman, S. E. & Kurbatova, E., May 1 2024, In: International Journal of Tuberculosis and Lung Disease. 28, 5, p. 243-248 6 p.Research output: Contribution to journal › Article › peer-review
-
Pharmacokinetic-Pharmacodynamic Evidence From a Phase 3 Trial to Support Flat-Dosing of Rifampicin for Tuberculosis
Ngo, H. X., Xu, A. Y., Velásquez, G. E., Zhang, N., Chang, V. K., Kurbatova, E. V., Whitworth, W. C., Sizemore, E., Bryant, K., Carr, W., Weiner, M., Dooley, K. E., Engle, M., Dorman, S. E., Nahid, P., Swindells, S., Chaisson, R. E., Nsubuga, P., Lourens, M. & Dawson, R. & 1 others, , Jun 15 2024, In: Clinical Infectious Diseases. 78, 6, p. 1680-1689 10 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Preferences and feasibility of long-acting technologies for treatment of hepatitis C virus in low- and middle-income countries: A survey of providers and policymakers
Gupta, N., Swindells, S., Scarsi, K. K., Furl, R., Thomas, D. L., Weld, E. D., Ofimboudem, J. D., Desalegn, H., Hamid, S., Rosas, A. D. L. T., Miranda, A. E., Owen, A., Rannard, S., Hiebert, L., Sun, K. & Ward, J. W., May 2024, In: Journal of Viral Hepatitis. 31, 5, p. 221-232 12 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
1-Year Incidence of Tuberculosis Infection and Disease Among Household Contacts of Rifampin- and Multidrug-Resistant Tuberculosis
for the AIDS Clinical Trials Group A5300/International Maternal Pediatric Adolescent AIDS Clinical Trials I2003 Protecting Households on Exposure to Newly Diagnosed Index Multidrug-resistant Tuberculosis Patients Feasibility Study Team* (Additional study group members are listed in the Acknowledgment section), Sep 15 2023, In: Clinical Infectious Diseases. 77, 6, p. 892-900 9 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations